Press Release: Building Trades Unions Weigh in on Drug Prices
Building Trade Unions Weigh in on Drug Prices Iron Workers General President Releases Statement Following President Trump’s Speech on Drug Prices View the statement in PDF. Eric Dean, General President of the International Association of Bridge, Structural, Ornamental and Reinforcing Ironworkers, released the following statement in response to President Trump’s speech on drug prices: The […]
Delaware State News: The culprits behind high prescription drug prices
James Maravelias, President of the Delaware AFL-CIO and Co-Chair of We Work for Health Delaware, authored the following op-ed for Delaware News Journal. May 14, 2018 View article on the Delaware News Journal website. Out-of-pocket health care costs rose by 3.9 percent in 2016, according to a new report by Health Affairs. That was the […]
PILMA Chairman Reaffirms Position on Intellectual Property Protections
On April 25, 2018, Ironworkers General President and PILMA Chairman Eric Dean sent the following letter to the Chairman and Ranking Member of the Senate Finance and House Ways and Means Committees. The letter reaffirms PILMA’s commitment to strong intellectual property protections both domestically and in agreements with other countries. View the letter here. “The Pharmaceutical […]
Center Maryland: Promote Policies that Nurture Innovation and Jobs to Produce Cures
Eric Dean, general president of the Iron Workers and Chairman of PILMA authored the following op-ed for Center Maryland. Click here to view on Center Maryland. The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition of companies in the biopharmaceutical industry and building construction trades unions, is committed to dual goals of fostering innovation of life-saving cures […]
Forbes: Is America Falling Short On Skills?
Eric Dean, general president of the Iron Workers and Bill Brown, CEO of Ben Hur Construction authored the following op-ed for Forbes. Click here to view the article on the Forbes website. As President Trump prepares to ramp up his push for an infrastructure package, many contractors and plant owners continue to report concerns over the […]
Bergen Record: Workers win when Jersey drug companies innovate
Greg Lalavee, Business Manager at the International Union of Operating Engineers Local 825, authored the following op-ed in the Bergen Record. Click here to view the article on the Bergen Record website. New Jersey’s nickname, “Medicine Chest of the World,” is backed up by the numbers. Our state is home to more than 3,000 life sciences establishments. Thirteen […]
Congressman Tom MacArthur Tours IUOE Local 825 in Dayton, NJ
On May 12, 2017 Congressman Tom MacArthur (R-NJ) and New Jersey Senate President Steve Sweeney toured the Operating Engineers Local 825 training center in Dayton, New Jersey. The event, hosted by We Work for Health NJ, the HealthCare Institute of New Jersey, Local 825 and PILMA, highlighted the rigorous training and apprenticeship programs that prepare members to build […]
PILMA Trustees Adopt Transparency and Importation Resolutions
At PILMA’s Trustees Meeting on February 8, 2017, the following two resolutions were passed in supporting the partnership’s mission of fostering innovation in the life sciences and the creation of high-quality union construction jobs. Resolution Concerning Transparency Legislation Resolution Concerning Illegal Importation of Biopharmaceuticals
Delaware News Journal: Delaware workers, companies must unite to confront threats
Sam Lathem, the former president of the Delaware AFL-CIO, authored the following op-ed in the Delaware News Journal. Click here to view the article on the News Journal website. This election season has featured the usual speeches about the importance of American workers and expanding job opportunities. And as usual, the statements have lacked detail, […]
Statement Concerning Unintended Consequences of CMS’ Proposed Medicare Part B Demonstration
The members of PILMA approved the following statement concerning the unintended consequences of CMS’ proposed Medicare Part B demonstration and its effect on patient access to needed medications. Click here to view the statement.